Clinical experiences using radium-223, a novel α-emitting bone-seeking radiopharmaceutical, in breast and prostate cancer patients with skeletal metastases

被引：0
|
作者：
Nilsson, S
Larsen, RH
Bruland, OS
机构：
[1] Norwegian Radium Hosp, Oslo, Norway
[2] Algeta ASA, Oslo, Norway
[3] Karolinska Hosp, S-10401 Stockholm, Sweden
来源：
CANCER TREATMENT REVIEWS | 2005年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
51
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [21] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
  • [22] NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases
    Umeweni, Nwamaka
    Knight, Helen
    McVeigh, Gary
    LANCET ONCOLOGY, 2016, 17 (03): : 275 - 276
  • [23] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
  • [24] Treatment of patients with castration-resistant prostate cancer and bone metastases with radium-223: A single institution experience
    Devarakonda, Srinivas S.
    Skweres, Justin
    Nair, Binu Sivaraman
    Dhawan, Manish
    Takalkar, Amol
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
    Cursano, M. C.
    Iuliani, M.
    Casadei, C.
    Stellato, M.
    Tonini, G.
    Paganelli, G.
    Santini, D.
    De Giorgi, U.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
  • [26] Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy
    Wenter, Vera
    Herlemann, Annika
    Fendler, Wolfgang P.
    Ilhan, Harun
    Tirichter, Natalia
    Bartenstein, Peter
    Stief, Christian G.
    la Fougere, Christian
    Albert, Nathalie L.
    Rominger, Axel
    Gratzke, Christian
    ONCOTARGET, 2017, 8 (27) : 44131 - 44140
  • [27] Efficacy and tolerance of radium-223 dichloride in patients treated for castration-resistant prostate cancer with bone metastases
    Awoudou, C.
    Bathily, E. H. A. L.
    Djigo, M. S.
    Ndong, B.
    Mbodj, M.
    Paulus, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (03): : 150 - 157
  • [28] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Uemura, Hiroji
    Uemura, Hirotsugu
    Matsubara, Nobuaki
    Kinuya, Seigo
    Hosono, Makoto
    Yajima, Yoko
    Doi, Toshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (05) : 954 - 963
  • [29] MICRODISTRIBUTION OF ALPHA PARTICLE EMITTING RADIUM-223 DICHLORIDE IN MODELS OF PROSTATE CANCER BONE METASTASIS
    Abou, Diane
    Ulmert, David
    Hobbs, Robert
    Riddle, Ryan
    Thorek, Daniel
    JOURNAL OF UROLOGY, 2015, 193 (04): : E551 - E551
  • [30] Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
    Kapoor, Anil
    Wong, Nathan C.
    Wang, Yuding
    Mukherjee, Som
    Hotte, Sebastien
    Dayes, Ian
    Lukka, Himu
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (04) : 437 - 438
12345